EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles

Himanshu Vishwakarma, Abhishek Chauhan, Loveleen Kaur, Ankit Awasthi iD

Journal of Pharmacy and Pharmacology · 02.06.2026 · 78 (6)

DOI: 10.1093/jpp/rgag060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 09.06.2026. Verfasst von Himanshu Vishwakarma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Nanoparticles, Drug Delivery Systems, Nanotechnology. Die Arbeit nennt 289 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Neurodegenerative disorders comprise a diverse group of progressive neurological diseases characterized by the gradual loss of neuronal structure and function. Conditions such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis arise from multifactorial mechanisms involving genetic susceptibility, environmental factors, and age-related cellular decline. Pathophysiology Key pathogenic processes include oxidative stress, mitochondrial dysfunction, protein misfolding and aggregation, impaired axonal transport, Golgi fragmentation, and chronic neuroinflammation, all of which disrupt neuronal homeostasis and synaptic communication, ultimately leading to neuronal death. Hormonal imbalances further exacerbate these effects by promoting oxidative damage, inflammation, and metabolic dysfunction. Challenges in Therapy Despite advances in understanding disease mechanisms, effective drug delivery remains challenging due to the restrictive nature of the blood–brain barrier. Nanotechnology-Based Therapeutic Strategies Recent developments highlight the potential of nanoparticle-based drug delivery systems to overcome these limitations. Functionalized nanoparticles enhance blood–brain barrier penetration, improve targeting specificity, and enable controlled drug release. These systems can deliver neuroprotective agents, antioxidants, peptides, and gene therapies directly to affected brain regions. Thus, integrating disease pathophysiology with nanotechnology-based strategies offers a promising approach for improving therapeutic outcomes and advancing precision treatment in neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesNanoparticlesDrug Delivery SystemsNanotechnologyHumansAnimalsBlood-Brain BarrierNeuroprotective AgentsOxidative Stress

Stichwörter der Autor:innen

functionalized nanoparticlesmitochondrial dysfunctionneurological disordersneurotherapeuticsoxidative stressreactive oxygen species

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.

ORCID-Profile: Ankit Awasthi

Zitieren

APA

Vishwakarma, H., Chauhan, A., Kaur, L., & Awasthi, A. (2026). Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles. Journal of Pharmacy and Pharmacology, 78(6). https://doi.org/10.1093/jpp/rgag060

Vancouver

Vishwakarma H, Chauhan A, Kaur L, Awasthi A. Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles. Journal of Pharmacy and Pharmacology. 2026;78(6). doi:10.1093/jpp/rgag060

BibTeX
@article{Vishwakarma2026,
  author = {Vishwakarma, Himanshu and Chauhan, Abhishek and Kaur, Loveleen and Awasthi, Ankit},
  title = {Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  volume = {78},
  number = {6},
  doi = {10.1093/jpp/rgag060}
}
Kostenlos starten →